Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer

In the scenario of systemic treatment for advanced non-small cell lung cancer (NSCLC) patients, one of the most relevant breakthroughs is represented by targeted therapies. Throughout the last years, inhibitors of the epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), c-Ros o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebuzzi, Sara Elena, Zullo, Lodovica, Rossi, Giovanni, Grassi, Massimiliano, Murianni, Veronica, Tagliamento, Marco, Prelaj, Arsela, Coco, Simona, Longo, Luca, Dal Bello, Maria Giovanna, Alama, Angela, Dellepiane, Chiara, Bennicelli, Elisa, Malapelle, Umberto, Genova, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961376/
https://www.ncbi.nlm.nih.gov/pubmed/33807876
http://dx.doi.org/10.3390/ijms22052625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961376/
https://www.ncbi.nlm.nih.gov/pubmed/33807876
http://dx.doi.org/10.3390/ijms22052625

Ejemplares similares